Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Extracorporeal Membrane Oxygenation (ECMO) System Market Insights

Extracorporeal membrane oxygenation system is a life supporting system providing cardiac and respiratory support to the patients suffering from severe respiratory failure. ECMO circuit comprises cannulas, pump, blender and oxygenator, which oxygenates the blood and remove carbon dioxide through extracorporeal gas exchange device referred as membrane oxygenator. The location of drainage and reinfusion port of cannulas determines the modality of the ECMO system. If drainage and reinfusion both are from central veins it is referred as venovenous ECMO or if it is from vein to artery it is referred to as venoarterial ECMO. Potential indications for which ECMO is used includes severe acute respiratory distress syndrome (ARDS), acute hypercapnic respiratory failure, to bridge lung transplantation, primary graft dysfunction post-lung transplantation, and pulmonary hypertension with right ventricular failure.

The global ECMO system market was valued at US$ 248.2 million in 2017, and is expected to witness a CAGR of 5.3 % over the forecast period (2018 – 2026).

Figure 2. Global Extracorporeal Membrane Oxygenation System Market, By Modality

extracorporeal membrane oxygenation system market

Source: Coherent Market Insights Analysis (2018)

Prevalence of Cardiac and Respiratory Diseases are Boosting Growth of the Extracorporeal Membrane Oxygenation System Market

Increasing cases of cardiovascular and respiratory disorders is one of the major factors that is boosting growth of the ECMO system market. For instance, according to World Health Organization (WHO), around 31% of total global deaths was due to cardiovascular disease in 2015, which accounted to nearly 17.7 million deaths. According to European Heart Network AISBL, about 3.9 million and over 1.8 million deaths occurs every year in Europe and European Union respectively, which accounted to nearly 45% of all deaths in European Union. Another factor expected for the growing success of ECMO system market over the forecast period is the rising number of organ transplant surgeries across the globe. For instance, according to Organ and Tissue Authority of Australian Government, the number of surgeries performed for organ transplant in 2017 were around 1,469. Moreover, according to Australia and New Zealand Organ Donation Registry around 1,400 Australians are waiting for organ transplant at any given time.

Also, high prevalence of diseases will lead to increasing demand for extracorporeal membrane oxygenation system in hospitals and surgical centers. For instance, according to annual international registry by Extracorporeal Life Support Organization (ELSO), 65,171 patients received ECMO system in 2015, which increased to 98,840 patients in 2018 out of which 40,256 were neonatal, 22,952 pediatrics, and 35,632 adults.

On the basis of region, extracorporeal oxygenation system market is segmented into North America, Latin America, Europe, Africa, Asia Pacific, and Middle East. North America is leading the ECMO system market, owing to various factors such as well-established healthcare infrastructure, government funds, and reimbursement framework. Moreover, high pool of Chronic Obstructive Pulmonary Disease (COPD) and other disorders are expected to fuel market growth in this region. Furthermore, around 85 million and 49 million people were suffering from cardiovascular disease in Europe and European Union, respectively in 2015. According to Centers for Disease Control and Prevention (CDC), COPD was the third leading cause of death with more than 15 million Americans diagnosed with COPD every year in 2011. Furthermore, Asia Pacific region is expected to gain significant traction in ECMO system market, attributed by advancements in healthcare system with support of government initiatives.

Industrial Collaboration by the Key Players is Fueling Extracorporeal Membrane Oxygenation System Market

The global extracorporeal membrane oxygenation system market is operated by Medtronic Plc., Getinge Group, LivaNova Plc., Terumo Corporation, Xenios AG, Microsoft Scientific Co., Origen Biomedical, Eurosets S.R.L., Nipro Corporation and Alung technologies Inc. The industry players are adopting the strategy of collaboration focusing on development of new products. For instance, in 2018, Medtronic Plc. collaborated with the Sayler Biomedical LLC, for the development of their product Century heart Lung machine. The collaboration has made the Medtronic’s product available for customers globally. Century heart lung machine has features, such as compact and sturdy design, easy to use components and affordable price. This is expected to strengthen customer base and widen the product portfolio of Medtronic.

Extracorporeal membrane oxygenation (ECMO) assists cardiopulmonary functions outside the body. Based on the location of drainage and reinfusion there are 3 different types of extracorporeal membrane oxygenation system which are arteriovenous, venoarterial and venovenous whereas on the bases of age, it is classified into neonatal, pediatric and adult. The growing number of congenital heart defects, increase the demand for ECMO. For instance, according to American Heart Association, approximately 40,000 babies are born with a congenital heart defect in United States each year and around 2 to 3 million individuals are living with a congenital heart defect.

Market Dynamics

The growth of ECMO market is due to factors like increasing prevalence of cardiovascular and chronic respiratory disease such as asthma, chronic obstructive pulmonary disease (COPD), occupational lung disease or pulmonary hypertension. For instance, in 2014, Centers for Disease Control and Prevention (CDC) reported 1,417,101 deaths globally due to chronic respiratory disease. Moreover, increasing implementation of ECMO will also swell the ECMO system market. According to National Center for Biotechnology Information, ECMO is effective and growing means of life support for the patients with swine flu infection by bridging the gap, between respiratory distress to total body recovery. Further, medical policies such as Premera, supports extracorporeal membrane oxygenation (ECMO) in adults may be considered medically necessary for the management of acute respiratory failure. On the flip side of the coin, the ECMO system market is expected to be hampered by the complications associated with the ECMO system such as internal bleeding, blood clotting or technical failure.

Key features of the study:

  • This report provides in-depth analysis of the extracorporeal membrane oxygenation system market and its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global extracorporeal membrane oxygenation (ECMO) system market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Medtronic plc., Getinge Group, LivaNova Plc., Terumo Corporation, Xenios AG, Microsoft Scientific Co., Origen Biomedical, Eurosets S.R.L., Nipro Corporation, Alung technologies Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.
  • The global extracorporeal membrane oxygenation (ECMO) system market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for extracorporeal membrane oxygenation system market, research and consulting firms, new entrants and financial analysts

Detailed Segmentation:

  • Global Extracorporeal Membrane Oxygenation System Market, By Modality:
    • Arteriovenous
    • Venoarteial
    • Venovenous
  • Global Extracorporeal Membrane Oxygenation System Market, By Application:
    • Extracorporeal cardiopulmonary resuscitation
    • Cardiac
    • Respiratory
  • Global Extracorporeal Membrane Oxygenation System Market, By Age Group:
    • Neonatal
    • Pediatric
    • Adults
  • Global Extracorporeal Membrane Oxygenation System Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
      • By Modality
        • Arteriovenous
        • Venoarteial
        • Venovenous
      • By Application:
        • Extracorporeal cardiopulmonary resuscitation
        • Cardiac
        • Respiratory
      • By Age Group:
        • Neonatal
        • Pediatric
        • Adults
    • Europe
      • By Country
        • Germany
        • UK
        • France
        • Spain
        • Russia
        • Rest of Europe
      • By Modality
        • Arteriovenous
        • Venoarteial
        • Venovenous
      • By Application:
        • Extracorporeal cardiopulmonary resuscitation
        • Cardiac
        • Respiratory
      • By Age Group:
        • Neonatal
        • Pediatric
        • Adults
    • Asia-Pacific
      • By Country
        • China
        • India
        • South Korea
        • Japan
        • Australia
        • ASEAN
    • Rest of Asia-Pacific
      • By Modality
        • Arteriovenous
        • Venoarteial
        • Venovenous
      • By Application:
        • Extracorporeal cardiopulmonary resuscitation
        • Cardiac
        • Respiratory
      • By Age Group:
        • Neonatal
        • Pediatric
        • Adults
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Modality
        • Arteriovenous
        • Venoarteial
        • Venovenous
      • By Application:
        • Extracorporeal cardiopulmonary resuscitation
        • Cardiac
        • Respiratory
      • By Age Group:
        • Neonatal
        • Pediatric
        • Adults
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
      • By Modality
        • Arteriovenous
        • Venoarteial
        • Venovenous
      • By Application:
        • Extracorporeal cardiopulmonary resuscitation
        • Cardiac
        • Respiratory
      • By Age Group:
        • Neonatal
        • Pediatric
        • Adults
    • Africa
      • By Country
        • North Africa
        • Central Africa
        • South Africa
      • By Modality
        • Arteriovenous
        • Venoarteial
        • Venovenous
      • By Application:
        • Extracorporeal cardiopulmonary resuscitation
        • Cardiac
        • Respiratory
      • By Age Group:
        • Neonatal
        • Pediatric
        • Adults
  • Company Profiles
    • Medtronic plc. *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments
      • Strategies
    • Getinge Group
    • LivaNova Plc.
    • Terumo Corporation
    • Xenios AG
    • Microsoft Scientific Co.
    • Origen Biomedical
    • Eurosets S.R.L.
    • Nipro Corporation
    • Alung technologies Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Modality
      • Market Snippet, By Application
      • Market Snippet, By Age Group
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Technological Advancements
    • Industry Trends
    • PEST Analysis
    • PORTER’S Five Forces
  4. Global Extracorporeal Membrane Oxygenation System Market, By Modality, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Arteriovenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Venoarteial
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Venovenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  5. Global Extracorporeal Membrane Oxygenation System Market, By Application, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Extracorporeal cardiopulmonary resuscitation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Cardiac
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Respiratory
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Extracorporeal Membrane Oxygenation System Market, By Age Group, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Neonatal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Pediatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Adults
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  7. Global Extracorporeal Membrane Oxygenation System Market, By Region, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, By Region, 2016 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Modality, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Modality, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Modality, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Modality, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Modality, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Argentina
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Modality, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Medtronic Plc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Getinge Group
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • LivaNova Plc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Terumo Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Xenios AG
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Microsoft Scientific Co.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Origen Biomedical
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Eurosets S.R.L.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Nipro Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Alung technologies Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
  9. Section
    • References
    • Analyst Views
    • Research Methodology
    • About Us and Sales Contact

*Browse 36 market data tables and 32 figures on "Extracorporeal Membrane Oxygenation System Market - Global forecast to 2026”.

Frequently Asked Questions

The global extracorporeal membrane oxygenation system market is estimated to surpass US$ 375.1 Million by 2026.
Major players operating in the global extracorporeal membrane oxygenation system market include Medtronic Plc., Getinge Group, LivaNova Plc., Terumo Corporation, Xenios AG, Microsoft Scientific Co., Origen Biomedical, Eurosets S.R.L., Nipro Corporation, and Alung technologies Inc.
Among application, respiratory segment is expected to account for major market share, attributed to high incidence of respiratory disorders
Increasing cases of cardiovascular and respiratory disorders is one of the major factors that is expected to propel growth of the market over the forecast period.
The global extracorporeal membrane oxygenation system market is estimated to exhibit a CAGR of 5.3% over the forecast period.
Among regions, North Americais expected to hold dominant position in the global extracorporeal membrane oxygenation system market over the forecast period.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner